Quick Takeaways
- Pontifax Management 4 G.P. (2015) Ltd. filed SCHEDULE 13D for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share.
- Disclosed ownership: 6.3%.
- Date of event: 12 Sep 2025.
Pontifax Management 4 G.P. (2015) Ltd. - 12 Sep 2025 SCHEDULE 13D Report for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share
- Filing Manager
- Pontifax Management 4 G.P. (2015) Ltd.
- Reporting Manager
- Pontifax Management 4 G.P. (2015) Ltd.
- Shares outstanding
- 22,407,635 shares
- Disclosed Ownership
- 1,411,681 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13D
- Filing time
- 25 Sep 2025, 10:55:33 UTC
- Date of event
- 12 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Pontifax Management 4 G.P. (2015) Ltd. disclosed 6.3% ownership in LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share on 12 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Sep 2025, 10:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Pontifax Management 4 G.P. (2015) Ltd. | 6.3% | 1,411,681 | 0 | 1,411,681 | /s/ Ran Nussbaum | Ran Nussbaum Managing Partner | 0001726334 |
| Pontifax VI G.P. L.P. | 6.3% | 1,411,681 | 0 | 1,411,681 | /s/ Ran Nussmabum | Ran Nussbaum Managing Partner | |
| Ran Nussbaum | 6.3% | 1,411,681 | 0 | 1,411,681 | /s/ Ran Nussbaum | Ran Nussbaum | |
| Tomer Kariv | 6.3% | 1,411,681 | 0 | 1,411,681 | /s/ Tomer Kariv | Tomer Kariv |